Why Get the Oncotype DX Genomic Prostate Score Test?
If you have been diagnosed with low-risk prostate cancer, discussing management options with your doctor is typically the next step. It’s important that you give yourself time to understand what your diagnosis means, and what option will be best for your specific cancer at this specific time.
The Oncotype DX test gives you and your doctor more information for treatment conversations and decisions.
Oncotype DX is a genomic test, meaning that it measures the expression of certain genes in prostate cancer cells. The results of Oncotype DX are reported as a Genomic Prostate Score (GPS), which can help you and your doctor more confidently make decisions about a management plan that’s best for you.